Serological evidence of dengue fever and its associated factors in patients

Authors

  • Muhammad Salman Hameed Latif Hospital Lahore Pakistan
  • Nimra Nisar Hameed Latif Hospital Lahore Pakistan
  • Marium Younas Hameed Latif Hospital Lahore Pakistan
  • Faisal Iqbal Islam Medical & Dental College Sialkot Pakistan
  • Hira Afzal Hameed Latif Hospital Lahore Pakistan
  • Adnan Abdul Majid Hameed Latif Hospital Lahore Pakistan

DOI:

https://doi.org/10.59736/IJP.24.03.1102

Keywords:

Complete Blood Count, Dengue fever, IgG, IgM, Seroprevalence

Abstract

Background: Dengue virus (DENV), a viral infection, is transmitted to humans primarily through bites from infected mosquitoes called Aedes aegypti mosquitoes and, to a lesser extent by the Aedes albopictus mosquitoes. Globally, the incidence of dengue is increasing, with an estimated half of the world’s population at risk. This study aimed to evaluate serological   indicators of dengue and associated risk factors among patients.
Methods: A cross-sectional study conducted at Hameed Latif Hospital from 15 July 2024 to 30 September 2024. 490 patients were determined using G-POWER software. The study included all patients presenting to the emergency department with symptoms indicative of dengue during the study period. Data were analyzed with SPSS version 25. Frequency tables were presented for quantitative data, and the chi-square test was used for categorical variables (level of significance p<0.05).

Results: The overall seroprevalence of anti-DENV IgG and IgM antibodies was 23.7% and 7.6%, respectively. Of the 490 confirmed cases, 421 were male (58.8%), and 295 were female (41.2%). The highest incidence was observed in the 16–30 age group (42.0%), followed by 31–45 years (25.7%),above46years(18.4%),and0–15years(13.8%).
Conclusion: Dengue showed substantial seroprevalence, with significant associations with sex and residence. Common clinical manifestations and characteristic hematological abnormalities underscore the importance of early diagnosis, surveillance, and targeted preventive measures

Author Biographies

  • Muhammad Salman, Hameed Latif Hospital Lahore Pakistan

    Department of Medicine

  • Nimra Nisar, Hameed Latif Hospital Lahore Pakistan

    Department of Medicine

  • Marium Younas, Hameed Latif Hospital Lahore Pakistan

    Department of Medicine

  • Faisal Iqbal , Islam Medical & Dental College Sialkot Pakistan

    Department of Medicine

  • Hira Afzal , Hameed Latif Hospital Lahore Pakistan

    Department of Medicine

  • Adnan Abdul Majid, Hameed Latif Hospital Lahore Pakistan

    Department of Medicine

References

Wei Xiang BW, Saron WA, Stewart JC, Hain A, Walvekar V, et al. Dengue virus infection modifies mosquito blood-feeding behavior to increase transmission to the host. Proc Natl Acad Sci. 2022;119(3):e2117589119.

De Santis O, Bouscaren N, Flahault A. Asymptomatic dengue infection rate: a systematic literature review. Heliyon. 2023;9(9). doi.org/10.1016/j.heliyon.2023.e20069

Biswas PO, Ganguly SA, Debnath BI. Dengue fever: stages, complication, diagnosis, and prevention strategies. Asian J Pharm Clin Res. 2021;14(5):3-11. DOI: http://dx.doi.org/10.22159/ajpcr.2021v14i5.40960.

Arain SQ, Channa NA, Talpur FN, Memon NH, Sheikh M, Phull AR. Dengue Fever: Prevalence, Risk Factors and Serological Diagnosis in Hyderabad, Sindh, Pakistan. J Fatima Jinnah Med Univ. 2024;18(4):185-90. DOI: https://doi.org/10.37018/AXDS9956

Nigussie E. Seroprevalence of West Nile virus and associated factors in Borena District, Southern Ethiopia. Arch Infect Dis Ther. 2021;5(2):52-9.

Raza FA, Javed H, Khan MM, et al. Dengue and chikungunya virus co-infection in major metropolitan cities of provinces of Punjab and Khyber Pakhtunkhwa: a multi-center study. PLoS Negl Trop Dis. 2021;15(9):e0009802. doi:10.1371/journal.pntd.0009802

Qureshi H, Khan MI, Bae SJ, Akhtar S, Khattak AA, Haider A, et al. Prevalence of dengue virus in Haripur district, Khyber Pakhtunkhwa, Pakistan. J Infect Public Health.2023;16(7):1131-6. doi:10.1016/j.jiph.2023.04.021.

Atif M, Raheel U, Alam F, Arshad H, Baloch F, Imran M, et al. Serotyping of dengue virus from deadly outbreaks of Pakistan. J Hum Virol Retrovirol. 2016;3(3):00092. doi:10.15406/jhvrv.2016.03.00092.

World Health Organization. Dengue fever – Pakistan [Internet]. Geneva: World Health Organization; 2019 [cited 2020 Apr 1].https://www.who.int/csr/don/19-november-2019-dengue-pakistan/en/

Islam Z, Mohanan P, Bilal W, Hashmi T, Rahmat Z, Abdi I, et al. Dengue virus cases surge amidst COVID-19 in Pakistan: challenges, efforts and recommendations. Infect Drug Resist. 2022:367-71. doi:10.2147/IDR.S347571

Khan J, Khan I, Ghaffar A, Khalid B. Epidemiological trends and risk factors associated with dengue disease in Pakistan (1980-2014): a systematic literature search and analysis. BMC Public Health. 2018;18:745.

doi:10.1186/s12889-018-5676-2.

Asghar RM, Ashraf RR, Saheel K, Hussain A. An evaluation of hematological changes in paediatric dengue fever patients at a tertiary care hospital, Rawalpindi, during 2019 outbreak. J Rawalpindi Med Coll. 2021;25:208-12. doi:10.37939/jrmc.v25i2.1558.

Prestes-Carneiro LE, Barbosa Souza A, Belussi GL, Grande GHD, Bertacco EAM, Vieira AG, et al. Dengue outbreaks in a city with recent transmission in São Paulo state, Brazil. Int J Environ Health Res. 2024;34(3):1370–83. doi.org/10.1080/09603123.2023.2199972

Man O, Kraay A, Thomas R, Trostle J, Lee GO, Robbins C, et al. Characterizing dengue transmission in rural areas: a systematic review. PLoS Negl Trop Dis. 2023;17(6):e0011333. doi.org/10.1371/journal.pntd.0011333

Alsedig K, Eldigail MH, Elduma AH, Elaagip A, Altahir O, Siam HA, et al. Prevalence of malaria and dengue co-infections among febrile patients during dengue transmission season in Kassala, eastern Sudan. PLoS Negl Trop Dis.2023;17(10):e0011660. doi.org/10.1371/journal.pntd.0011660

Parker DM, Haileselassie W, Hailemariam TS, Workenh A, Workineh S, Wang X, et al. High Seroprevalence to Aedes-borne arboviruses in Ethiopia: a Cross-sectional Survey in 2024. medRxiv. 2024.

doi: 10.1101/2024.09.19.24313917

Salekwa LP. Serological evidence for Circulation of Dengue and Chikungunya antibodies in febrile patients in Mbeya Region,Tanzania.

doi.org/10.21203/rs.3.rs-5356883/v1

Li Z, Wang J, Cheng X, Hu H, Guo C, Huang J, et al. The worldwide seroprevalence of DENV, CHIKV and ZIKV infection: A systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;15(4):e0009337. doi.org/10.1371/journal.pntd.0009337

Umair M, Haider SA, Rehman Z, Jamal Z, Ali Q, Hakim R, et al. Genomic characterization of dengue virus outbreak in 2022 from Pakistan. Vaccines. 2023;11(1):163.

Yosef DK, Ismail AS, Awil BS, Hassan HA, Hassan MA. Epidemiology of dengue fever in Somaliland: clinical features, and serological patterns from a retrospective study. BMC Infect Dis. 2025;25(1):179.

doi.org/10.1186/s12879-025-10558-6

Nandwani, S., Bhakhri, B.K., Singh, N., Rai, R., Singh, D.K. Early hematological parameters as predictors for outcomes in children with dengue in northern India: A retrospective analysis. Rev Soc Bras Med Trop.2021;54:1-7.

doi.org/10.1590/0037-8682-0519-2020

Lim JK, Fernandes JF, Yoon I-K, Lee J-S, Mba RO, Lee KS, et al. Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambare´ne´ and its surroundings. PLoS Negl Trop Dis. 2021;15(2):01-15.

Wang, X., Li, T., Shu, Y., Zhang, J., Shan, X., Li, D., et al. Clinical characteristics and risk-factors for severe dengue fever in Xishuangbanna, during the dengue out-breakin 2019. Front Microbiol.2021;13:1-9. doi.org/10.3389/fmicb.2022.739970.

Downloads

Published

2026-10-09

Issue

Section

Original article

How to Cite

1.
Salman M, Nisar N, Younas M, Iqbal F, Afzal H, Majid AA. Serological evidence of dengue fever and its associated factors in patients. Int J Pathol [Internet]. 2026 Oct. 9 [cited 2026 Oct. 10];24(3):351-9. Available from: https://www.jpathology.com/index.php/OJS/article/view/1102